Beta-blockers in heart failure with preserved ejection fraction: a meta-analysis

C Bavishi, S Chatterjee, S Ather, D Patel… - Heart failure …, 2015 - Springer
Beta-blockers are established drugs in heart failure with reduced ejection fraction, but their
role in heart failure with preserved ejection fraction (HFpEF) is not established. Hence, we …

Effect of personalized accelerated pacing on quality of life, physical activity, and atrial fibrillation in patients with preclinical and overt heart failure with preserved …

M Infeld, K Wahlberg, J Cicero, TB Plante… - JAMA …, 2023 - jamanetwork.com
Importance Patients with heart failure with preserved ejection fraction (HFpEF) with a
pacemaker may benefit from a higher, more physiologic backup heart rate than the nominal …

[HTML][HTML] Sex-related differences in the pharmacological treatment of heart failure

J Tamargo, R Caballero, E Delpon - Pharmacology & Therapeutics, 2022 - Elsevier
Heart failure (HF) represents a leading cause of morbidity and mortality. However, HF trials
highlighted many differences between men and women with HF. Thus, women represent …

Beta-blocker use and heart failure outcomes in mildly reduced and preserved ejection fraction

SV Arnold, DN Silverman, K Gosch, ME Nassif, M Infeld… - Heart Failure, 2023 - jacc.org
Background Although studies consistently show that beta-blockers reduce morbidity and
mortality in patients with reduced ejection fraction (EF), data are inconsistent in patients with …

Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fraction

LH Lund, L Benson, U Dahlström, M Edner, L Friberg - Jama, 2014 - jamanetwork.com
Importance Heart failure with preserved ejection fraction (HFPEF) may be as common and
may have similar mortality as heart failure with reduced ejection fraction (HFREF). β …

Reduced myocardial flow in heart failure patients with preserved ejection fraction

K Srivaratharajah, T Coutinho, R deKemp… - Circulation: Heart …, 2016 - Am Heart Assoc
Background—There remains limited insight into the pathophysiology and therapeutic
advances directed at improving prognosis for patients with heart failure with preserved …

Heart failure with mid-range ejection fraction

PK Srivastava, JJ Hsu, B Ziaeian… - Current heart failure reports, 2020 - Springer
Heart Failure With Mid-range Ejection Fraction | Current Heart Failure Reports Skip to main
content SpringerLink Account Menu Find a journal Publish with us Track your research Search …

Accelerated atrial pacing reduces left-heart filling pressure: a combined clinical-computational study

T van Loon, J Rijks, J van Koll, J Wolffs… - European Heart …, 2024 - academic.oup.com
Abstract Background and Aims Accelerated atrial pacing offers potential benefits for patients
with heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) …

Association is not causation: treatment effects cannot be estimated from observational data in heart failure

CJ Rush, RT Campbell, PS Jhund… - European heart …, 2018 - academic.oup.com
Aims Treatment 'effects' are often inferred from non-randomized and observational studies.
These studies have inherent biases and limitations, which may make therapeutic inferences …

The effect of beta-blockers on mortality in heart failure with preserved ejection fraction: A meta-analysis of observational cohort and randomized controlled studies

H Fukuta, T Goto, K Wakami, N Ohte - International Journal of Cardiology, 2017 - Elsevier
Background Nearly half of patients with heart failure (HF) have preserved ejection fraction
(EF) and the mortality of patients with HF with preserved EF (HFpEF) is high. However, there …